|
HIC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.21890000004399E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.28320046097497E-10 |
| Normal-vs-Stage2 |
6.014300E-02 |
| Normal-vs-Stage3 |
5.048500E-02 |
| Normal-vs-Stage4 |
6.009200E-01 |
| Stage1-vs-Stage2 |
3.921700E-02 |
| Stage1-vs-Stage3 |
2.660800E-03 |
| Stage1-vs-Stage4 |
1.28820000000474E-07 |
| Stage2-vs-Stage3 |
8.208200E-01 |
| Stage2-vs-Stage4 |
1.429790E-01 |
| Stage3-vs-Stage4 |
1.511410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17289999999704E-05 |
| Normal-vs-AfricanAmerican |
4.846700E-04 |
| Normal-vs-Asian |
2.629200E-01 |
| Caucasian-vs-AfricanAmerican |
8.273700E-02 |
| Caucasian-vs-Asian |
7.926600E-01 |
| AfricanAmerican-vs-Asian |
6.497000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.520740E-03 |
| Normal-vs-Female |
3.16589999771466E-08 |
| Male-vs-Female |
4.619400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.749700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.25579999996373E-06 |
| Normal-vs-Age(61-80Yrs) |
2.016600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.387420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.974600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.988400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.118200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.739800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.105000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.844200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.625400E-04 |
| Normal-vs-Grade 2 |
1.64809998981497E-09 |
| Normal-vs-Grade 3 |
3.779300E-03 |
| Normal-vs-Grade 4 |
4.025200E-01 |
| Grade 1-vs-Grade 2 |
1.218450E-02 |
| Grade 1-vs-Grade 3 |
2.622500E-04 |
| Grade 1-vs-Grade 4 |
3.032600E-04 |
| Grade 2-vs-Grade 3 |
2.081900E-03 |
| Grade 2-vs-Grade 4 |
1.88089999131336E-09 |
| Grade 3-vs-Grade 4 |
9.006600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.31334959469132E-12 |
| Normal-vs-ccB subtype |
8.554600E-01 |
| ccA subtype-vs-ccB subtype |
6.69686528453894E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.207100E-04 |
| Normal-vs-N1 |
1.977050E-01 |
| N0-vs-N1 |
2.080000E-03 |
|
|
